Conversations with the HPTN

Dr. Hyman Scott, HTPN 083 protocol team member and co-investigator for HPTN 091 at Bridge HIV in San Francisco, is the clinical research medical director at Bridge HIV and an assistant clinical professor of Medicine at the University of California, San Francisco.

Dr. Susan Buchbinder, HPTN 091 investigator, is director of Bridge HIV, a grant-funded research unit housed in the San Francisco Department of Public Health. She is also a clinical professor of Medicine and Epidemiology at UCSF, where she attends at San Francisco General Hospital and teaches in the Training in Clinical Research program.

Pamela Thandeka Tshandu, an HPTN 083-01 and HPTN 084-01 protocol team member, is a community liaison officer at Wits RHI in Johannesburg. Her work focuses on promoting the inclusion of all populations in HIV/AIDS prevention research, ensuring clinical trials are innovative, efficient, and timely.

Dr. Kate MacQueen is a longstanding HPTN Ethics Working Group (EWG) representative supporting HPTN 096, HPTN 083-01, HPTN 084-01, and the Women-at-Risk Scientific Working Group. Dr.